United States · Who invested in Arialys Therapeutics?
Arialys Therapeutics's investors include Alexandria Venture Investments.
20242025
$58MSeed$15MVenture
United States · Venture startup
Who invested in Arialys Therapeutics
Funding summaryUpdated 26 Oct 2026
$73Mraised across 2 rounds since 2023, from 2 sources
$58MSeed$15MVenture
- Latest round
- Venture, $15MJun 2025
- Biggest round
- $58MSeed · Sept 2023
- Investors
- 1
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Seed, $58M Sept 2023
- Biggest round
- $58M Seed · Sept 2023
- Between rounds
- 21 months from the last two
The rounds
- Jun 2025Venture$15M1 returning
Source recordedSEC filing: $15M sold, first sale Jun 2025
- Sept 2023
Founders and team
From Arialys Therapeutics's own website: 2 on the team.
- April PurcellDirector, Clinical Operations
- Jeff LittlerBoard of Directors
Quick answers about Arialys Therapeutics
How much has Arialys Therapeutics raised?
Arialys Therapeutics has raised $73M across 2 rounds since 2023.
When did Arialys Therapeutics last raise?
Arialys Therapeutics's most recent round was a Venture of $15M in Jun 2025.
What was Arialys Therapeutics's biggest round?
Arialys Therapeutics's largest round on record is $58M (Seed), in Sept 2023.
Who backed Arialys Therapeutics first?
Arialys Therapeutics's first round on record, in Sept 2023, was backed by Alexandria Venture Investments.
What stage is Arialys Therapeutics at?
Arialys Therapeutics's latest named round is a Venture, in Jun 2025.
Where is Arialys Therapeutics based?
Arialys Therapeutics is based in the United States.
Companies like Arialys Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.